San Francisco General Hospital
San Francisco General Hospital
San Francisco, California, United States15 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era | Blood-Borne Infections, Genital Diseases, HIV infectious disease, Infections, RNA Virus Infections, Urogenital Diseases, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, sexually transmitted disease, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease | Recruiting | Not stated | 2026-09-08 | NCT00187512 | |
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Recruiting | Phase 3 | 2026-08-20 | NCT07227246 | |
| Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials | Stroke, Acute, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, ischemic stroke, nervous system disorder, stroke disorder, vascular disorder | Recruiting | Not stated | 2026-08-20 | NCT05338697 | |
| VictORION-INCLUSION: Evaluating Inclisiran for Cholesterol Managment in Heart Disease | Arterial Occlusive Diseases, Dyslipidemias, Hypercholesterolemia, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, atherosclerosis, atherosclerotic cardiovascular disease, cardiovascular disorder, hyperlipidemia, metabolic disease, vascular disorder | Active, not recruiting | Phase 4 | 2026-07-29 | NCT06249165 | |
| Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity | Chronic Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms | Recruiting | Not applicable | 2026-07-27 | NCT06183281 | |
| Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection | HIV | Active, not recruiting | Phase 4 | 2026-07-17 | NCT02656511 | |
| Anticoagulation in ICH Survivors for Stroke Prevention and Recovery | Arrhythmias, Cardiac, Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, heart disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Recruiting | Phase 3 | 2026-05-08 | NCT03907046 | |
| The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies | HIV | Recruiting | Not stated | 2026-05-01 | NCT01202305 | |
| The Use of Leukapheresis to Support HIV Pathogenesis Studies | HIV | Recruiting | Not stated | 2026-05-01 | NCT01161199 | |
| Collection of Blood for Multiple Collaborative Studies | HIV | Recruiting | Not stated | 2026-04-13 | NCT01336855 | |
| The APS Phenotyping Study | Critical Illness, Disease Attributes, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiration Disorders, Sepsis, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Recruiting | Not stated | 2026-02-20 | NCT06521502 | |
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, intracerebral hemorrhage, nervous system disorder, vascular disorder | Active, not recruiting | Phase 3 | 2026-01-21 | NCT03496883 | |
| Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial) | Arterial Occlusive Diseases, Blood-Borne Infections, Dyslipidemias, Genital Diseases, HIV infectious disease, Infections, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, RNA Virus Infections, Urogenital Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, immune system disorder, inborn error of immunity, infectious disease, lentivirus infection, metabolic disease, sexually transmitted disease, uterine carcinosarcoma, vascular disorder, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2025-12-17 | NCT05488431 | |
| Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform in Correlation to TcPO2 | Arterial Occlusive Diseases, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, peripheral arterial disease, peripheral vascular disease, vascular disorder | Active, not recruiting | Not applicable | 2025-11-12 | NCT04514861 | |
| Technology Assisted Motivational Interviewing | Smoking; Smoking Cessation | Recruiting | Not applicable | 2025-10-23 | NCT06713603 |